Clinical Trials Browser

Phase NA × Neoplasms, Plasma Cell × Lenalidomide × Clear all

NCT01927718 2019-04-29

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Phase NA Terminated

10 enrolled 5 charts

Multiple Myeloma, Neoplasms, Plasma Cell